Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV VaccineAlphavirus infectious disease, Encephalitis, Arbovirus, Encephalitis, Viral, Encephalomyelitis, Equine, Infections, Mosquito-Borne Diseases, Neuroinflammatory Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, encephalomyelitis, infectious encephalitis, nervous system disorder, vector-borne disease, viral infection of central nervous system, viral infectious diseaseActive, not recruitingPhase 22025-10-01NCT06899802

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bavarian Nordic9
JPM CBRN Medical1

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Benchmark ResearchSan AngeloUnited States1
Benchmark ResearchKennerUnited States1
Benchmark ResearchSacramentoUnited States2
Clay-Platte Family Medicine, P.C./CCT ResearchKansas CityUnited States1
Jefferson City Medical Group / AvacareJefferson CityUnited States1
Johnson County Clin-TrialsLenexaUnited States5
Lifeline Primary Care, Inc. / CCT ResearchLilburnUnited States1
Papillion Research Center/CCT ResearchPapillionUnited States2
Versailles Family Medicine, PLLC/CCT ResearchVersaillesUnited States1